VX-770 is a highly efficacious potentiator that is used clinically to treat people with CF who have gating and residual function CFTR mutations, including the more common gating mutation, G551D [4,5,6,7,8,9,10,11]. This evidence concerns the gene CFTR and cystic fibrosis.